Utility of soluble lectin-like oxidized low-density lipoprotein receptor-1 (sLOX-1) in the postmortem diagnosis of ischemic heart disease.

[1]  A. Valenzuela,et al.  Cardiac troponin T determination by a highly sensitive assay in postmortem serum and pericardial fluid , 2016, Forensic Science, Medicine, and Pathology.

[2]  M. Petzold,et al.  High-sensitive cardiac troponin, NT-proBNP, hFABP and copeptin levels in relation to glomerular filtration rates and a medical record of cardiovascular disease. , 2015, Clinical biochemistry.

[3]  Chaitanya Vidyadhar Tingne,et al.  Distribution & diagnostic efficacy of cardiac markers CK-MB & LDH in pericardial fluid for postmortem diagnosis of ischemic heart disease. , 2014, Journal of forensic and legal medicine.

[4]  Nobuaki Kobayashi,et al.  Soluble lectin-like oxidized LDL receptor-1 (sLOX-1) as a valuable diagnostic marker for rupture of thin-cap fibroatheroma: verification by optical coherence tomography. , 2013, International journal of cardiology.

[5]  A. Catapano,et al.  Soluble Lectin-Like Oxidized Low Density Lipoprotein Receptor-1 as a Biochemical Marker for Atherosclerosis-Related Diseases , 2013, Disease markers.

[6]  Nobuaki Kobayashi,et al.  Detection of acute aortic dissection by extremely high soluble lectin-like oxidized LDL receptor-1 (sLOX-1) and low troponin T levels in blood. , 2013, International journal of cardiology.

[7]  J. Moss,et al.  LOX-1 in atherosclerosis: biological functions and pharmacological modifiers , 2012, Cellular and Molecular Life Sciences.

[8]  A. Ludwig,et al.  The role of ADAM-mediated shedding in vascular biology. , 2012, European journal of cell biology.

[9]  Mary Jo Kurth,et al.  Diagnostic accuracy of heart-type fatty acid-binding protein for the early diagnosis of acute myocardial infarction. , 2012, The American journal of emergency medicine.

[10]  Nobuaki Kobayashi,et al.  Soluble lectin-like oxidized LDL receptor-1 and high-sensitivity troponin T as diagnostic biomarkers for acute coronary syndrome. Improved values with combination usage in emergency rooms. , 2011, Circulation journal : official journal of the Japanese Circulation Society.

[11]  T. Michiue,et al.  Combined analyses of creatine kinase MB, cardiac troponin I and myoglobin in pericardial and cerebrospinal fluids to investigate myocardial and skeletal muscle injury in medicolegal autopsy cases. , 2011, Legal medicine.

[12]  R. Twerenbold,et al.  N-terminal pro B-type natriuretic peptide in the early evaluation of suspected acute myocardial infarction. , 2011, The American journal of medicine.

[13]  Nobuaki Kobayashi,et al.  Soluble lectin-like oxidized low-density lipoprotein receptor-1 as an early biomarker for ST elevation myocardial infarction: time-dependent comparison with other biomarkers: time-dependent comparison with other biomarkers. , 2011, Circulation journal : official journal of the Japanese Circulation Society.

[14]  C. Zhang,et al.  CRP enhances soluble LOX-1 release from macrophages by activating TNF-α converting enzyme , 2011, Journal of Lipid Research.

[15]  T. Kita,et al.  Soluble lectin-like oxidized LDL receptor-1 (sLOX-1) as a sensitive and specific biomarker for acute coronary syndrome--comparison with other biomarkers. , 2010, Journal of cardiology.

[16]  Nicholas I. Batalis,et al.  The Role of Postmortem Cardiac Markers in the Diagnosis of Acute Myocardial Infarction * , 2010, Journal of forensic sciences.

[17]  T. Kita,et al.  Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts prognosis after acute coronary syndrome--a pilot study. , 2010, Circulation journal : official journal of the Japanese Circulation Society.

[18]  S. Del Turco,et al.  The lectin-like oxidized low-density lipoprotein receptor-1 and its soluble form: cardiovascular implications. , 2010, Journal of atherosclerosis and thrombosis.

[19]  H. Sasai,et al.  Weight reduction can decrease circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in overweight middle-aged men. , 2009, Metabolism: clinical and experimental.

[20]  L. Leng,et al.  Soluble lectin-like oxidized low density lipoprotein receptor-1 in type 2 diabetes mellitus This study was supported by funding from the Hong Kong Research Grants Council (Grant HKU 7585/05M). Published, JLR Papers in Press, April 12, 2008. , 2008, Journal of Lipid Research.

[21]  P. Mangin,et al.  Evaluation of postmortem measurement of NT-proBNP as a marker for cardiac function , 2008, International Journal of Legal Medicine.

[22]  T. Michiue,et al.  Postmortem cardiac troponin I and creatine kinase MB levels in the blood and pericardial fluid as markers of myocardial damage in medicolegal autopsy. , 2007, Legal medicine.

[23]  Xiangzhi Meng,et al.  Heart fatty acid binding protein as a marker for postmortem detection of early myocardial damage. , 2006, Forensic science international.

[24]  T. Michiue,et al.  Postmortem pericardial natriuretic peptides as markers of cardiac function in medico-legal autopsies , 2006, International Journal of Legal Medicine.

[25]  T. Michiue,et al.  Postmortem cardiac troponin T levels in the blood and pericardial fluid. Part 1. Analysis with special regard to traumatic causes of death. , 2006, Legal medicine.

[26]  T. Michiue,et al.  Postmortem cardiac troponin T levels in the blood and pericardial fluid. Part 2: analysis for application in the diagnosis of sudden cardiac death with regard to pathology. , 2006, Legal medicine.

[27]  M. Pfisterer,et al.  Use of N-terminal pro-B-type natriuretic peptide to detect myocardial ischemia. , 2005, The American journal of medicine.

[28]  Takeshi Kimura,et al.  Serum Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Levels Are Elevated in Acute Coronary Syndrome: A Novel Marker for Early Diagnosis , 2005, Circulation.

[29]  A. Chetrit,et al.  The composition of normal pericardial fluid and its implications for diagnosing pericardial effusions. , 2005, The American journal of medicine.

[30]  C. Ellingsen,et al.  Serum Concentrations of Cardiac Troponin T in Sudden Death , 2004, The American journal of forensic medicine and pathology.

[31]  A Luna,et al.  Diagnostic efficacy of biochemical markers in diagnosis post-mortem of ischaemic heart disease. , 2004, Forensic science international.

[32]  R. Renneberg,et al.  A superior early myocardial infarction marker , 2004, Zeitschrift für Kardiologie.

[33]  S. Chihara,et al.  Influence of renal function on serum and urinary heart fatty acid-binding protein levels. , 2001, The Journal of cardiovascular surgery.

[34]  T. Kita,et al.  Identification of soluble forms of lectin-like oxidized LDL receptor-1. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[35]  T. Kita,et al.  Expression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions. , 1999, Circulation.

[36]  A Luna,et al.  Distribution of biochemical markers in biologic fluids: application to the postmortem diagnosis of myocardial infarction. , 1998, The American journal of forensic medicine and pathology.

[37]  M. Simoons,et al.  Fatty acid-binding protein and the early detection of acute myocardial infarction. , 1998, Clinica chimica acta; international journal of clinical chemistry.

[38]  M. Plebani,et al.  Diagnostic strategies using myoglobin measurement in myocardial infarction. , 1998, Clinica chimica acta; international journal of clinical chemistry.

[39]  Y. Kihara,et al.  Marked elevation of brain natriuretic peptide levels in pericardial fluid is closely associated with left ventricular dysfunction. , 1998, Journal of the American College of Cardiology.

[40]  R. Doughty,et al.  Immunoreactive amino‐terminal pro‐brain natriuretic peptide (NT‐PROBNP): a new marker of cardiac impairment , 1997, Clinical endocrinology.

[41]  H. Naruse,et al.  Serum concentrations of myoglobin vs human heart-type cytoplasmic fatty acid-binding protein in early detection of acute myocardial infarction. , 1997, Clinical chemistry.

[42]  T. Kita,et al.  An endothelial receptor for oxidized low-density lipoprotein , 1997, Nature.

[43]  J. Maessen,et al.  Discrimination between myocardial and skeletal muscle injury by assessment of the plasma ratio of myoglobin over fatty acid-binding protein. , 1995, Circulation.

[44]  H. Morita,et al.  Human heart-type cytoplasmic fatty acid-binding protein in serum and urine during hyperacute myocardial infarction. , 1993, International journal of cardiology.

[45]  W S Kilpatrick,et al.  Early Diagnosis of Acute Myocardial Infarction: CK-MB and Myoglobin Compared , 1993, Annals of clinical biochemistry.

[46]  J. Drouin,et al.  Differential expression of natriuretic peptide genes in cardiac and extracardiac tissues. , 1991, Molecular endocrinology.

[47]  J. Mair,et al.  Cardiac troponin T in diagnosis of acute myocardial infarction. , 1991, Clinical chemistry.

[48]  K. Inouye,et al.  Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. , 1991, The Journal of clinical investigation.

[49]  Y. Hirota,et al.  Serum and urinary human heart fatty acid-binding protein in acute myocardial infarction. , 1991, Clinical biochemistry.

[50]  A. Remppis,et al.  Diagnostic Efficiency of Troponin T Measurements in Acute Myocardial Infarction , 1991, Circulation.

[51]  P. Brecher,et al.  Characterization and amino acid sequence of a fatty acid-binding protein from human heart. , 1988, The Biochemical journal.

[52]  H. Gold,et al.  Diagnosis of acute myocardial infarction by detection of circulating cardiac myosin light chains. , 1984, The American journal of cardiology.

[53]  J. Gere,et al.  A radioimmunoassay for the measurement of human cardiac myosin light chains. , 1979, American journal of clinical pathology.

[54]  P. Ludbrook,et al.  Specificity of elevated serum MB creatine phosphokinase activity in the diagnosis of acute myocardial infarction. , 1975, The American journal of cardiology.

[55]  S. Perry,et al.  Phosphorylation of the light-chain components of myosin from cardiac and red skeletal muscles. , 1975, The Biochemical journal.

[56]  R. Rosati,et al.  The Importance of Identification of the Myocardial‐Specific Isoenzyme of Creatine Phosphokinase (MB Form) in the Diagnosis of Acute Myocardial Infarction , 1973 .

[57]  I. Lodge-Patch.  THE AGEING OF CARDIAC INFARCTS, AND ITS INFLUENCE ON CARDIAC RUPTURE , 1951, British heart journal.

[58]  T. Kita,et al.  Interleukin 18 stimulates release of soluble lectin-like oxidized LDL receptor-1 (sLOX-1). , 2009, Atherosclerosis.